Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes. This evidence concerns the gene BRS3 and obesity due to melanocortin 4 receptor deficiency.